The Evicel Post-Authorization Surveillance Study

Inclusion Criteria: * Subjects, 18 years or older, requiring elective, primary or repeat vascular procedures with at least one end-to-side anastomosis to the femoral artery or to an upper extremity artery * EVICEL Fibrin Sealant is used as an adjunct to obtain haemostasis at a target anastomosis/es * Subjects must be willing to and capable of participating in the study, and provide written informed consent Exclusion Criteria: * Subjects with known intolerance to blood products * Subjects unwilling to receive blood products * Subjects with any intra-operative findings that may preclude the use of a fibrin sealant to control suture line anastomotic bleeding * Subject participating in another study with an investigational (pre-approved) drug or device within 30 days of surgery